Cormorant Asset Management, LP

Holdings History for Rapport Therapeutics, Inc. - Common Stock, $0.001 par value per share (RAPP)

Symbol
RAPP on Nasdaq
Investment type
Equity / Common Stock, $0.001 par value per share
Latest Disclosed Shares Owned
3,027,521 shares
Security Ownership %
6.4%
Shares, Excluding Options vs Price
Value, Excluding Options

Cormorant Asset Management, LP ownership in Rapport Therapeutics, Inc. Common Stock, $0.001 par value per share (RAPP)

17 Feb 2026 - Cormorant Asset Management, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,027,521 shares of Rapport Therapeutics, Inc. Common Stock, $0.001 par value per share (RAPP). This represents 6.4% ownership of the company. In their previous filing dated 14 Nov 2025, Cormorant Asset Management, LP had reported owning 3,192,521 shares, indicating a decrease of +5.2%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.